Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


Superbugs & Superdrugs - A Focus on Antibacterials

04 Mar 2013 - 05 Mar 2013 - London, UK



Bookmark and Share


SMi is proud to present their 15th annual conference on Superbugs and Superdrugs that will explore EMA approach to regulating antimicrobials, strategies to target multi-drug resistant gram-negative bacteria and the current developments in public/private partnerships. 

This discussion led event will bring together senior Pharma representatives and key academics to discuss current developments in this fast-paced field. With presentations from industry representatives from all over the pharmaceutical sector, this event promises to be a unique platform for networking and problem solving.

KEY TOPICS FOR 2013

Regulatory requirements for antimicrobial developers

Mechanism of action studies of peptidomimetic antibiotics

DARQs as candidates for tuberculosis treatment

Novel direct antiviral agent discovery; case study on Simeprevir

Combating fungal infections

Strategic aspects on forming partnerships with BARDA

Overcoming challenges in implementing the European Commission’s action plan against antimicrobial resistance

For more information visit http://www.smi-online.co.uk/goto/superbugssuperdrugs7.asp or contact Fateja Begum on tel +44 0207 827 6184 or email fbegum@smi-online.co.uk 




Further information
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!